| MSCOX | WCMNX | MSCOX / WCMNX | |
| Total Expense Ratio | 2.10 | 1.24 | 169% |
| Annual Report Gross Expense Ratio | 2.29 | 2.04 | 112% |
| Fund Existence | 9 years | 7 years | - |
| Gain YTD | 11.875 | 11.144 | 107% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 239M | 51.9M | 461% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 5.92 | 16.65 | 36% |
| Returns for 3 years | 66.20 | 31.41 | 211% |
| Returns for 5 years | -47.74 | 1.76 | -2,717% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AFRU | 10.99 | 0.45 | +4.26% |
| T-REX 2X Long AFRM Daily Target ETF | |||
| LFSC | 47.80 | 0.35 | +0.75% |
| F/m Emerald Life Sciences Innovation ETF | |||
| SPXX | 19.08 | 0.09 | +0.47% |
| Nuveen S&P 500 Dynamic Overwrite Fund | |||
| IBND | 31.37 | 0.01 | +0.03% |
| State Street® SPDR® Blmbg Intl CorpBdETF | |||
| CPSF | 26.50 | N/A | N/A |
| Calamos S&P 500 Str Alt Prt ETF-Feb | |||